Search
Leader | 00000nz a2200037n 45 0 | ||
---|---|---|---|
001 | WKP|Q57066466 (VIAF cluster) (Authority/Source Record) | ||
003 | WKP | ||
005 | 20241121000121.0 | ||
008 | 241121nneanz||abbn n and d | ||
035 | ‡a (WKP)Q57066466 | ||
024 | ‡a 0000-0002-4866-731X ‡2 orcid | ||
035 | ‡a (OCoLC)Q57066466 | ||
100 | 0 | ‡a Emma Robinson ‡9 es ‡9 ast | |
375 | ‡a 2 ‡2 iso5218 | ||
400 | 0 | ‡a এমা রবিনসন ‡9 bn | |
400 | 0 | ‡a Emma Robinson ‡c researcher ‡9 en | |
400 | 0 | ‡a Emma Robinson ‡c onderzoeker ‡9 nl | |
670 | ‡a Author's Anthracycline-Related Heart Failure: Certain Knowledge and Open Questions: Where Do we Stand with Chemotherapyinduced Cardiotoxicity? | ||
670 | ‡a Author's Approaching Sex Differences in Cardiovascular Non-Coding RNA Research | ||
670 | ‡a Author's Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129 | ||
670 | ‡a Author's Contractile responses to endothelin-1 are regulated by PKC phosphorylation of cardiac myosin binding protein-C in rat ventricular myocytes. | ||
670 | ‡a Author's Endothelin-1 promotes hypertrophic remodelling of cardiac myocytes by activating sustained signalling and transcription downstream of endothelin type A receptors | ||
670 | ‡a Author's Experimental heart failure modelled by the cardiomyocyte-specific loss of an epigenome modifier, DNMT3B | ||
670 | ‡a Author's Hepatocyte-Specific SR-BI Gene Transfer Corrects Cardiac Dysfunction in Scarb1-Deficient Mice and Improves Pressure Overload-Induced Cardiomyopathy | ||
670 | ‡a Author's Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection | ||
670 | ‡a Author's Lnc'ing Ca2+, SERCA and cardiac disease | ||
670 | ‡a Author's Mutations in PDLIM5 are rare in dilated cardiomyopathy but are emerging as potential disease modifiers | ||
670 | ‡a Author's Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure | ||
670 | ‡a Author's Regulatory RNAs in Heart Failure | ||
670 | ‡a Author's Resistance to retinopathy development in obese, diabetic and hypertensive ZSF1 rats: an exciting model to identify protective genes | ||
670 | ‡a Author's The H3K9 dimethyltransferases EHMT1/2 protect against pathological cardiac hypertrophy | ||
670 | ‡a Author's The landscape of DNA repeat elements in human heart failure | ||
670 | ‡a Author's The Missing "lnc" between Genetics and Cardiac Disease | ||
909 | ‡a (orcid) 000000024866731x ‡9 1 | ||
919 | ‡a hepatocytespecificsrbigenetransfercorrectscardiacdysfunctioninscarb1deficientmiceandimprovespressureoverloadinducedcardiomyopathy ‡A Hepatocyte-Specific SR-BI Gene Transfer Corrects Cardiac Dysfunction in Scarb1-Deficient Mice and Improves Pressure Overload-Induced Cardiomyopathy ‡9 1 | ||
919 | ‡a experimentalheartfailuremodelledbythecardiomyocytespecificlossofanepigenomemodifierdnmt3b ‡A Experimental heart failure modelled by the cardiomyocyte-specific loss of an epigenome modifier, DNMT3B ‡9 1 | ||
919 | ‡a endothelin1promoteshypertrophicremodellingofcardiacmyocytesbyactivatingsustainedsignallingandtranscriptiondownstreamofendothelintypeareceptors ‡A Endothelin-1 promotes hypertrophic remodelling of cardiac myocytes by activating sustained signalling and transcription downstream of endothelin type A receptors ‡9 1 | ||
919 | ‡a contractileresponsestoendothelin1areregulatedbypkcphosphorylationofcardiacmyosinbindingprotein100inratventricularmyocytes ‡A Contractile responses to endothelin-1 are regulated by PKC phosphorylation of cardiac myosin binding protein-C in rat ventricular myocytes. ‡9 1 | ||
919 | ‡a catalyzingtranscriptomicsresearchincardiovasculardiseasethecardiornacostactionca17129 ‡A Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129 ‡9 1 | ||
919 | ‡a resistancetoretinopathydevelopmentinobesediabeticandhypertensivezsf1ratsanexcitingmodeltoidentifyprotectivegenes ‡A Resistance to retinopathy development in obese, diabetic and hypertensive ZSF1 rats: an exciting model to identify protective genes ‡9 1 | ||
919 | ‡a approachingsexdifferencesincardiovascularnoncodingrnaresearch ‡A Approaching Sex Differences in Cardiovascular Non-Coding RNA Research ‡9 1 | ||
919 | ‡a regulatoryrnasinheartfailure ‡A Regulatory RNAs in Heart Failure ‡9 1 | ||
919 | ‡a anthracyclinerelatedheartfailurecertainknowledgeandopenquestionswheredowestandwithchemotherapyinducedcardiotoxicity ‡A Anthracycline-Related Heart Failure: Certain Knowledge and Open Questions: Where Do we Stand with Chemotherapyinduced Cardiotoxicity? ‡9 1 | ||
919 | ‡a myofibroblastphenotypeandreversibilityoffibrosisinpatientswithendstageheartfailure ‡A Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure ‡9 1 | ||
919 | ‡a mutationsinpdlim5arerareindilatedcardiomyopathybutareemergingaspotentialdiseasemodifiers ‡A Mutations in PDLIM5 are rare in dilated cardiomyopathy but are emerging as potential disease modifiers ‡9 1 | ||
919 | ‡a h3k9dimethyltransferasesehmt12protectagainstpathologicalcardiachypertrophy ‡A The H3K9 dimethyltransferases EHMT1/2 protect against pathological cardiac hypertrophy ‡9 1 | ||
919 | ‡a missinglncbetweengeneticsandcardiacdisease ‡A The Missing "lnc" between Genetics and Cardiac Disease ‡9 1 | ||
919 | ‡a landscapeofdnarepeatelementsinhumanheartfailure ‡A The landscape of DNA repeat elements in human heart failure ‡9 1 | ||
919 | ‡a lncingca2+sercaandcardiacdisease ‡A Lnc'ing Ca2+, SERCA and cardiac disease ‡9 1 | ||
919 | ‡a humanembryonicstemcellderivedcardiomyocyteplatformscreensinhibitorsofsarscov2infection ‡A Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection ‡9 1 | ||
946 | ‡a a ‡9 1 | ||
996 | ‡2 BIBSYS|1542227324254 | ||
996 | ‡2 SUDOC|196256836 | ||
996 | ‡2 PLWABN|9810535647405606 | ||
996 | ‡2 J9U|987007375681705171 | ||
996 | ‡2 RERO|A003752030 | ||
996 | ‡2 ISNI|0000000483074389 | ||
996 | ‡2 J9U|987007314874705171 | ||
996 | ‡2 SUDOC|156466058 | ||
996 | ‡2 NTA|421511893 | ||
996 | ‡2 BIBSYS|90121906 | ||
996 | ‡2 J9U|987007326033405171 | ||
996 | ‡2 SUDOC|081488831 | ||
996 | ‡2 LC|n 2007165496 | ||
996 | ‡2 LC|n 2007090346 | ||
996 | ‡2 LC|nb2012017265 | ||
996 | ‡2 NTA|136314147 | ||
996 | ‡2 LC|nb2011009989 | ||
996 | ‡2 N6I|vtls002452691 | ||
996 | ‡2 LNB|LNC10-000346959 | ||
996 | ‡2 SUDOC|100491928 | ||
996 | ‡2 ISNI|0000000074283454 | ||
996 | ‡2 LC|no2015043632 | ||
996 | ‡2 LC|n 2017182542 | ||
996 | ‡2 LC|n 85008840 | ||
996 | ‡2 SUDOC|273729306 | ||
996 | ‡2 RERO|A003752017 | ||
996 | ‡2 DNB|1176689045 | ||
996 | ‡2 LC|no2019103767 | ||
996 | ‡2 RERO|A003752018 | ||
996 | ‡2 J9U|987007274901505171 | ||
996 | ‡2 BAV|495_249453 | ||
996 | ‡2 DNB|1219988669 | ||
996 | ‡2 BAV|495_249454 | ||
996 | ‡2 NUKAT|n 2009105512 | ||
996 | ‡2 NKC|xx0023409 | ||
996 | ‡2 NTA|363988904 | ||
996 | ‡2 ISNI|0000000025255289 | ||
996 | ‡2 LC|n 88068059 | ||
996 | ‡2 BNF|17868154 | ||
996 | ‡2 RERO|A027756119 | ||
996 | ‡2 DNB|1142184099 | ||
996 | ‡2 NTA|160369452 | ||
996 | ‡2 ISNI|0000000109498587 | ||
996 | ‡2 LC|n 2014187328 | ||
996 | ‡2 ISNI|0000000036175831 | ||
996 | ‡2 LC|n 82158400 | ||
996 | ‡2 DNB|136679455 | ||
996 | ‡2 NKC|xx0312738 | ||
996 | ‡2 DNB|1319489524 | ||
996 | ‡2 PLWABN|9811263828905606 | ||
996 | ‡2 ISNI|000000040146144X | ||
996 | ‡2 ISNI|0000000038446121 | ||
996 | ‡2 DNB|113727249X | ||
996 | ‡2 DNB|132967992X | ||
996 | ‡2 LC|n 85064118 | ||
996 | ‡2 ISNI|0000000077926371 | ||
996 | ‡2 ISNI|0000000456017928 | ||
996 | ‡2 PTBNP|140205 | ||
996 | ‡2 NUKAT|n 2018253424 | ||
996 | ‡2 BNF|12520812 | ||
996 | ‡2 CAOONL|ncf11055131 | ||
996 | ‡2 LC|n 2024002049 | ||
996 | ‡2 ISNI|0000000042065540 | ||
996 | ‡2 DNB|104250402 | ||
996 | ‡2 LC|no2014047642 | ||
996 | ‡2 SZ|136679455 | ||
996 | ‡2 BIBSYS|90401189 | ||
996 | ‡2 LC|no 98062060 | ||
996 | ‡2 N6I|vtls000014499 | ||
996 | ‡2 BIBSYS|90232199 | ||
996 | ‡2 NTA|44365039X | ||
996 | ‡2 NII|DA12807014 | ||
996 | ‡2 PTBNP|249762 | ||
996 | ‡2 LC|no2010060458 | ||
996 | ‡2 ISNI|0000000082524078 | ||
996 | ‡2 LC|nb2006010918 | ||
996 | ‡2 ISNI|000000006300435X | ||
996 | ‡2 LC|no 95040035 | ||
996 | ‡2 ISNI|0000000030795810 | ||
996 | ‡2 SUDOC|236915207 | ||
996 | ‡2 LC|no2013021229 | ||
996 | ‡2 DNB|1318722292 | ||
996 | ‡2 NLA|000035766257 | ||
997 | ‡a 0 0 lived 0 0 ‡9 1 |